Skip to content

Janssen-Cilag

Active Public limited companyfounded 1975active for 51 yearsAntwerpseweg 15-17, 2340 BeerseKBO/BCE: BE 0415.283.427 subsidiary of Janssen Pharmaceutica#1 employer in Beerse, Wholesale and retail trade sector
Part of the group Johnson & Johnson 13 companies in 6 countries
See the group
Janssen-Cilag
Follow ReportCompare

Board

3 directors, 3 in day-to-day management, 1 auditor, no change since 2024
Nicoleta-Roxana Botea
Chair of the board, director and managing director
chair of the board appointed by deed of 11-10-2024 director since 01-09-2024 term until 11-06-2030
listed in the 2025 annual accounts, filed on 06-07-2026
Marleen Hoebus
Director and managing director
director since 09-08-2021 managing director appointed by deed of 15-04-2022 term until 14-06-2027
listed in the 2025 annual accounts, filed on 06-07-2026
Luc Van Oevelen
Director and managing director
director current term since 28-06-2024 managing director appointed by deed of 15-04-2022 6-year term from 2024
listed in the 2025 annual accounts, filed on 06-07-2026
BV PwC Bedrijfsrevisoren
Statutory auditor, permanent representative Roel Boons
current term since 27-06-2025 term of 3 financial years from 2025
listed in the 2025 annual accounts, filed on 06-07-2026
Luc Van Oevelen, Marleen Hoebus, Nicoleta-Roxana Botea
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Two directors jointly, or a managing director alone
deed of 10-07-2024

Office holders in the KBO →

Mandates through the years

22 names, the dashed line is today
Show
Luc Van Oevelen
Director, Managing director
Marleen Hoebus
Director, Managing director
Nicoleta-Roxana Botea
Chair of the board, Director, Managing director
BV PwC Bedrijfsrevisoren
Statutory auditor
Maria Fernanda De Almeida Prado
Managing director
VANDEWAERDE Gert
Managing director
Sonja Willems
Managing director
Wim De Vos
Director
Piet Vanden Bossche
Director
Ken Tignol
Director
Annemie De Dier
Director
Christian De La Porte
Director
Filip Standaert
Director
Luc Dierckx
Director
Peter Van Laeken
Director
Bart van Zijll Langhout
Managing director
Herman Van Hoof
Director
Pierre Patrick Paul Dewilde
Director
Marc Van Steenbergen
Chair of the board
Jacques Henri Joseph Peeters
Director
Kris Sterkens
Managing director
David Norton
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
  • Luc Van Oevelen
    • Director, appointed by deed of 26-02-2013, still in office
    • Managing director, appointed by deed of 15-04-2022, still in office
  • Marleen Hoebus
    • Director, from 09-08-2021 to date
    • Managing director, appointed by deed of 15-04-2022, still in office
  • Nicoleta-Roxana Botea
    • Director, from 01-09-2024 to date
    • Chair of the board, from 01-09-2024 to date
    • Managing director, appointed by deed of 11-10-2024, still in office
  • BV PwC Bedrijfsrevisoren
    • Statutory auditor, appointed by deed of 12-07-2010, still in office
  • Maria Fernanda De Almeida Prado
    • Director, from 01-10-2021 to 11-10-2024
    • Chair of the board, appointed by deed of 05-11-2021, ended, last mentioned on 05-11-2021
    • Managing director, appointed by deed of 05-11-2021, until 11-10-2024
  • VANDEWAERDE Gert
    • Director, appointed by deed of 14-10-2021, until 16-06-2023
    • Managing director, appointed by deed of 15-04-2022, until 16-06-2023
  • Sonja Willems
    • Chair of the board, appointed by deed of 16-03-2012, ended, last mentioned on 16-03-2012
    • Director, appointed by deed of 13-03-2012, until 01-11-2021
    • Managing director, appointed by deed of 16-03-2012, until 01-11-2021
  • Wim De Vos
    • Director, appointed by deed of 21-12-2017, until 09-08-2021
  • Piet Vanden Bossche
    • Director, appointed by deed of 15-10-2012, until 01-02-2018
  • Ken Tignol
    • Director, appointed by deed of 03-10-2016, until 01-11-2017
  • Annemie De Dier
    • Director, appointed by deed of 26-02-2013, until 01-09-2016
  • Christian De La Porte
    • Director, appointed by deed of 26-05-2010, until 01-02-2013
  • Filip Standaert
    • Director, appointed by deed of 15-10-2012, until 01-02-2013
  • Luc Dierckx
    • Director, from before 18-05-2009 to 01-10-2012
  • Peter Van Laeken
    • Director, appointed by deed of 20-10-2010, until 01-10-2012
  • Bart van Zijll Langhout
    • Director, appointed by deed of 29-06-2009, until 01-03-2012
    • Chair of the board, appointed by deed of 08-04-2010, until 01-03-2012
    • Managing director, appointed by deed of 08-04-2010, until 01-03-2012
  • Herman Van Hoof
    • Director, appointed by deed of 05-06-2008, until 15-10-2010
  • Pierre Patrick Paul Dewilde
    • Director, appointed by deed of 20-06-2005, until 01-04-2010
  • Marc Van Steenbergen
    • Chair of the board, appointed by deed of 29-06-2009, no longer listed in the 2025 annual accounts
  • Jacques Henri Joseph Peeters
    • Director, appointed by deed of 04-09-2006, until 18-05-2009
  • Kris Sterkens
    • Director, until 18-05-2009
    • Managing director, until 18-05-2009
  • David Norton
    • Director, until 01-08-2006

Control

Parent
Janssen Pharmaceutica
Equity €11.68bn
Profit €1.46bn in 2025 (profit €2.63bn in 2024)
Checked score 90
99.99%
This company
Janssen-Cilag
Equity €101.3m
Profit €30.9m in 2025

and 2 other shareholders

Capital

Capital
€13,525,741.20
Shares
2,534,430 in the 2025 annual accounts
Contribution per share
€5.34
Equity per share
€39.97 in 2025
Source
deed of 13-12-2010

Owners through the years

as the annual accounts name them
Janssen Pharmaceutica
99.99%
99.99%
Johnson & Johnson International US
0.01%
0.01%
Johnson & Johnson US
consolidatesconsolidates
consolidates
Johnson & Johnson Inc. US
consolidates until 2020
Owners as a list

Source: shareholder structure in its own accounts, parent in its own accounts

Articles of association

deed of 16-12-2019 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Monday of June at 10:00

Shareholders

3 owners

Owners 3

Capital transactions

Capital over time
  1. 13-12-2010 Capital reduction of €474,258.80 · to €13,525,741.20 · “zonder vernietiging van aandelen”
  2. 01-09-2010 Capital stated in the deed · €14,000,000

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure